FXR (NR1H4) modulating compounds
US11247986B2 · kind B2 · utility
1Cited by
24References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 10, 2019 |
| Grant date | Feb 15, 2022 |
| Priority date | — |
| Expiry date | May 10, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates generally to compounds which bind to the NR1H4 receptor (FXR) and act as agonists of FXR. The disclosure further relates to the use of the compounds for the preparation of a medicament for the treatment of diseases and/or conditions through binding of said nuclear receptor by said compounds and to a process for the synthesis of said compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.